NanoViricides
NNVC
51 hedge funds and large institutions have $5.47M invested in NanoViricides in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 14 closing their positions.
0.05% less ownership
Funds ownership: 0.38% → 0.33% (-0.05%)
7% less funds holding
Funds holding: 55 → 51 (-4)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
38% less capital invested
Capital invested by funds: $8.85M → $5.47M (-$3.38M)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$116K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
+$96.6K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$56.9K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$39.1K |
| 5 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$29.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$505K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$218K |
| 3 |
SCM
Segantii Capital Management
Hong Kong
|
-$183K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$178K |
| 5 |
Goldman Sachs
New York
|
-$150K |
NNVC Hedge Fund Activity: Q2 2016 in Review
51 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2016, worth a combined $5.47M — down 38% from $8.85M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of NNVC and 10 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $116K. The largest seller was TFS Capital, exiting entirely with an estimated $505K sold.
- 51 institutional investors held NanoViricides (NNVC) as of Q2 2016, down from 55 in Q1 2016.
- Funds reported $5.47M of NanoViricides stock for Q2 2016, down 38% quarter-over-quarter.
- 10 funds opened new NanoViricides positions in Q2 2016 and 14 closed out, a net change of -4 holders.
- The largest NanoViricides buyer in Q2 2016 was Renaissance Technologies, an estimated $116K added.
- The largest NanoViricides seller in Q2 2016 was TFS Capital, an estimated $505K sold.
Based on aggregated 13F filings for Q2 2016.